AI In Healthcare Roundtables
AI In Healthcare Roundtables
October 16, 2024 (Biopharmaceuticals)
October 30, 2024 (Medical Technologies)
Virtual

These roundtables will convene U.S. industry representatives and government officials to discuss strategies to increase U.S. industry competitiveness and support adoption and commercialization of artificial intelligence.

AI In Healthcare Roundtables

AI in Healthcare Roundtables

ITA’s Office of Health Industries is hosting two roundtable discussions with industry representatives and U.S. government officials on strategies to increase U.S. industry competitiveness and support adoption and commercialization of AI in the U.S. biopharmaceutical and medical technologies industries. ITA looks forward to hearing from U.S. industry stakeholders for their individual views on AI issues at these roundtables and through other AI engagements—please email HealthAI@trade.gov to be in touch with ITA experts on the topic.  

Roundtable 1: AI in Biopharmaceuticals Industry Roundtable

This roundtable discussion will explore strategies to increase U.S. industry competitiveness and support adoption of AI in the U.S. biopharmaceutical industry, including in drug discovery and development, biopharmaceutical manufacturing, clinical trial design, and supply chain management.

  • Roundtable Details: October 16, 2024 at 2:30pm – 4:30pm EDT (Virtual)
  • Discussion: ITA welcomes individual input and views regarding overseas competitiveness of U.S. companies using, or planning to incorporate, AI in how they produce and commercialize biopharmaceuticals. A non-exhaustive list of possible discussion topics is listed on the Federal Register Notice.
  • Selection: To attend, participants must submit an application package to HealthAI@trade.gov by no later than October 9, 2024. For more information on how to apply for the roundtable and selection criteria, please refer to the Federal Register Notice. ITA will evaluate registrations based on the submitted information and criteria on a rolling basis until a maximum of 20 participants have been selected.  

Roundtable 2: AI-Enabled Medical Technologies Industry Roundtable

This roundtable discussion will explore strategies to increase U.S. industry competitiveness and support commercialization of U.S.-produced AI-enabled medical technologies.  

  • Roundtable Details: October 30, 2024 at 2:30pm – 4:30pm EDT (Virtual)
  • Discussion: ITA welcomes individual input and views regarding overseas competitiveness of U.S. companies producing, or planning to produce, and exporting AI-enabled medical technologies. A non-exhaustive list of possible discussion topics is listed on the Federal Register Notice.
  • Selection: To attend, participants must submit an application package to HealthAI@trade.gov by no later than October 23, 2024. For more information on how to apply for the roundtable and selection criteria, please refer to the Federal Register Notice. ITA will evaluate registrations based on the submitted information and criteria on a rolling basis until a maximum of 20 participants have been selected.